Abstract
Since the discovery of SUMOs (small ubiquitin-like modifiers) over 20 years ago, sumoylation has recently emerged as an important posttranslational modification involved in almost all aspects of cellular physiology. In neurons, sumoylation dynamically modulates protein function and consequently plays an important role in neuronal maturation, synapse formation and plasticity. Thus, the dysfunction of sumoylation pathway is associated with many different neurological disorders. Hundreds of different proteins implicated in the pathogenesis of neurological disorders are SUMO-modified, indicating the importance of sumoylation involved in the neurological diseases. In this review, we summarize the growing findings on protein sumoylation in neuronal function and dysfunction. It is essential to have a thorough understanding on the mechanism how sumoylation contributes to neurological diseases in developing efficient therapy for these diseases.
Keywords: Sumoylation, neurological diseases, neuronal function, synapse formation.
Current Molecular Medicine
Title:SUMOylation in Neurological Diseases
Volume: 16 Issue: 10
Author(s): F.-Y. Liu, Y.-F. Liu, Y. Yang, Z.-W. Luo, J.-W. Xiang, Z.-G. Chen, R.-L. Qi, T.-H. Yang, Y. Xiao, W.-J. Qing and D. W.-C. Li
Affiliation:
Keywords: Sumoylation, neurological diseases, neuronal function, synapse formation.
Abstract: Since the discovery of SUMOs (small ubiquitin-like modifiers) over 20 years ago, sumoylation has recently emerged as an important posttranslational modification involved in almost all aspects of cellular physiology. In neurons, sumoylation dynamically modulates protein function and consequently plays an important role in neuronal maturation, synapse formation and plasticity. Thus, the dysfunction of sumoylation pathway is associated with many different neurological disorders. Hundreds of different proteins implicated in the pathogenesis of neurological disorders are SUMO-modified, indicating the importance of sumoylation involved in the neurological diseases. In this review, we summarize the growing findings on protein sumoylation in neuronal function and dysfunction. It is essential to have a thorough understanding on the mechanism how sumoylation contributes to neurological diseases in developing efficient therapy for these diseases.
Export Options
About this article
Cite this article as:
Liu F.-Y., Liu Y.-F., Yang Y., Luo Z.-W., Xiang J.-W., Chen Z.-G., Qi R.-L., Yang T.-H., Xiao Y., Qing W.-J. and Li W.-C. D., SUMOylation in Neurological Diseases, Current Molecular Medicine 2016; 16 (10) . https://dx.doi.org/10.2174/1566524017666170109125256
DOI https://dx.doi.org/10.2174/1566524017666170109125256 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antibody Based Therapies in Acute Leukemia
Current Drug Targets Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued) Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Micro- and Nano-particulate Strategies for Antigen Specific Immune Tolerance to Treat Autoimmune Diseases
Pharmaceutical Nanotechnology Silencing the Brain May be Better than Stimulating it. The GABA Effect
Current Pharmaceutical Design Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters miR-27b-3p is Highly Expressed in Serum of Patients with Preeclampsia and has Clinical Significance
Endocrine, Metabolic & Immune Disorders - Drug Targets Drugs and Aggression
Recent Patents on CNS Drug Discovery (Discontinued) Crohns Targeted Therapy: Myth or Real Goal?
Current Drug Discovery Technologies Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Current Genomics Gas Chromatography-electron Capture Detection Method for Determination of Polyols in the Urine
Current Organic Chemistry Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials
Medicinal Chemistry The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Neuroinflammation in Sepsis: Sepsis Associated Delirium
Cardiovascular & Hematological Disorders-Drug Targets Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage
Current Medicinal Chemistry Methamphetamine and HIV Infection, Role in Neurocognitive Dysfunction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Genetic and Environmental Factors in Complex Neurodevelopmental Disorders
Current Genomics Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension
Current Hypertension Reviews Sepsis-induced Cardiomyopathy
Current Cardiology Reviews